North America Alzheimer's Drugs Market Analysis and Forecast 2031
The rising burden of Alzheimer’s disease across the United States, Canada, and Mexico is accelerating demand for advanced therapeutics, innovative biologics, and early-stage treatment solutions. Increasing life expectancy and the expanding geriatric population are contributing to a higher prevalence of neurodegenerative disorders, encouraging pharmaceutical companies to strengthen...
0 Комментарии 0 Поделились 21 Просмотры 0 предпросмотр